If similar clinical variables are integrated into AI-driven models alongside PAH-specific markers like NT-proBNP and echocardiographic data, they could provide a promising alternative for early, non-invasive SSc-PAH detection without necessitating the direct involvement of a specialist. This evidence concerns the gene NPPB and pulmonary arterial hypertension.